Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

Recruiting now · Not applicable

Conditions studied: ITP - Immune Thrombocytopenia

In brief

this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.

Key facts

Study ID

NCT07093606

Run by

Sohag University

People needed

100

Starts

2025-07-14

Expected to finish

2026-01-20

Last updated by the study team

2025-07-30

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Pre-existing liver disease (e.g., hepatitis, cirrhosis, NAFLD). Concurrent use of hepatotoxic drugs. Patients lost to follow-up.

Where it is running

• Sohag university hospital — Sohag, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.